A diagnosis of 4 stage ovarian cancer can be devastating. However, advances in medical science are helping patients and offering them hope ...

CHICAGO — The addition of relacorilant to nab-paclitaxel significantly extended survival for women with platinum-resistant ovarian cancer, according to results of the randomized phase 3 ROSELLA ...

AVAILABLE 24/7. WELL, AN ASSISTANT PROFESSOR AT THE UNIVERSITY OF NEW MEXICO HAS JUST RECEIVED A GRANT TO CONDUCT MORE ...

Little is known about what causes ovarian cancer, and there is no way to detect it early yet. About 75% of the time when ...

Little is known about what causes ovarian cancer, and there is no way to detect it early yet. About 75% of the time when ...

Ovarian cancer in particular ... doesn't have great survival,” said one researcher. “Anything we can do to better understand ...

Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with ...

The Food and Drug Administration (FDA) has granted accelerated approval to Avmapki ™ (avutometinib) plus Fakzynja ™ (defactinib) for the treatment of adult patients with KRAS- ...

Ditch these lifestyle habits that could be raising your ovarian cancer risk.(Image by Pexels) The average overall 5-year survival rates are approximately 48.6 per cent.